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doi:10.1016/j.kjms.2012.02.015Abstract Successful blood pressure (BP) control requires good adherence to medication and
specific health-related behaviors. However, the BP control rate is not optimal, and limited
research has focused on the patient’s perspective. This study aimed at investigating the illness
perceptions of hypertensive patients and how they relate to drug adherence. One hundred and
seventeen hypertensive patients enrolled in this study, and data were collected in a family
physician clinic of a medical center located in northern Taiwan. The Illness Perception Ques-
tionnaire was administered, and medication adherence and demographic data were also
collected. Results showed the patients’ perceptions of their hypertension, that it was a chron-
ically severe but stable disease, and the patients were confident in the effectiveness of
medical treatments and their ability to control their disease. The participants were divided
into three clusters by cluster analysis. There were 46.15% participants in the first cluster; they
had less negative belief in their illness consequence and less negative emotional responses, but
a low personal sense of control. The second cluster (11.97%) had more negative emotional
responses and more negative beliefs in their illness consequence, but these individuals scored
highly on their personal sense of control and treatment control beliefs. The third cluster
(41.88%) had scores between clusters 1 and 2. Cluster 1 had the best drug adherence, and
cluster 2 had the worst drug adherence (c2Z 7.67, p < 0.05). It may be beneficial for clinical
physicians to pay attention to patients’ illness perceptions, including their negative emotional
response and symptoms, in order to improve their drug adherence.
Copyright ª 2012, Elsevier Taiwan LLC. All rights reserved., Nanya South Road, Banciao
l.com (C.-D. Chen).
vier Taiwan LLC. All rights reservIntroduction
Hypertension is an important risk factor for cardiovascular
disease and is prevalent in adults in Taiwan [1]. The World
Health Organization estimates that 62% of cardiovasculared.
Patients’ illness perception and adherence 443disease is related to poor blood pressure control [2].
However, the control rate of hypertensive adults was <30%
in 2002 according to the Taiwanese Survey on Hypertension,
Hyperglycemia, and Hyperlipidemia (TwSHHH) [1]. The
effective control of hypertension requires patients to take
medication regularly [3] and to maintain a healthy lifestyle
[4,5]. Unfortunately, the medication adherence rate is
generally w50e70% [6,7], and the adherence to diet,
exercise and other nonpharmacological interventions is
lower [8]. Determining the manner of increasing patient
adherence in these therapeutic regimens has been the core
of the relevant behavior research.
A literature review on patient adherence revealed that
many previous studies have been based on the assumption
that patients should be passive and obey medical instruc-
tions, and little attention has been paid to patients’ ideas
about medicine [9]. However, patients’ acceptance of
medical advice and information may be influenced by their
subjective beliefs about their health condition. Therefore,
it is essential to take these beliefs into account when giving
health advice or medical treatment. Several factors have
been identified as resulting in the nonadherence of hyper-
tensive patients, such as a lack of association of symptoms
to hypertension, the complexity of the therapy prescribed,
or possible side-effects. All these factors that patients are
concerned about with regard to their illness may be
conceptualized as patients’ illness perceptions.
Leventhal and his colleagues proposed the common-
sense model (CSM) of illness representation to understand
the processes by which people make sense of illness [10].
CSM considers that the main purpose of health behavior is
to deal with cognitive and emotional aspects of health
threats. Individuals are active problem-solvers when they
make decisions about their health behavior; they search for
information to determine the meaning of physical symp-
toms and try a variety of coping behaviors and modified
behaviors after evaluating their effectiveness. CSM assumes
that individuals create their own illness representation by
obtaining available concrete or abstract information, and
indicates that the schema of representation includes
formed, activated and modified responses to a variety
factors, such as symptoms, previous knowledge and infor-
mation from experts (e.g., physicians) and laypeople [11].
It has been demonstrated that patients generally have
negative perceptions about their illness; for instance,
a large number of symptoms associated with the condition
means more severe consequences. These perceptions may
be important determinants of treatment adherence and
functional recovery [11,12]. A recent study suggests that
hypertensive patients perceive medications to be neces-
sary, but a substantial proportion have concerns about
taking medicines [13]. Research using the CSM found that
when hypertensive patients believe that the treatment is
effective, they have a higher medication adherence rate. If
patients have fewer symptoms to predict hypertension and
high personal control of the disease, they then have better
health behavior adherence [14]. If the patient thinks that
hypertension is chronic and controllable (and, thus, lower
in negative consequences and emotion), then the adher-
ence correlates with emotion and personal control [13].
Thus, we can assume that patients’ perceptions of hyper-
tension have an important role in adherence.The aims of this study were as follows: (1) to investigate
the illness perceptions of hypertensive patients; and (2) to
identify different illness perceptions and how they relate to
drug adherence and patient characteristics.
Methods
Design and participants
This research was a cross-sectional study. After obtaining
ethical approval from the local Human Rights Committee,
data were collected from June 2009 to March 2010 in
a family physician clinic of a medical center located in
northern Taiwan. Patients who met the following criteria
were invited to participate in this study: (1) aged 20 years
or older; (2) a diagnosis of essential hypertension confirmed
by a family physician; (3) a prescription for antihyperten-
sive medication before the study; and (4) no complicating
condition with hypertension. One hundred and forty-four
hypertensive patients were recruited, and complete data
were collected from 117 participants. Written informed
consent was obtained from all participants.
Measures
Illness Perception Questionnaire-revised (IPQ-R)
((Hypertension), translated version)
The IPQ-R (Hypertension) was modified from the IPQ-R [15],
which is the most commonly used instrument that assesses
patients’ views of illness [16]. IPQ-R (Hypertension) is
comprised of three components: illness representation,
cause and identity. The illness representation consists of 23
questions with seven subscales, including timeline, cyclical
timeline, consequences, treatment control, personal
control, coherence and emotional representation. All items
were ranked on a five-point Likert scale (1, strongly
disagree to 5, strongly agree). The items of the IPQ-R
(Hypertension) were exactly the same as those of the
IPQ-R, except that items with confusing wording were
eliminated. The scoring of the IPQ-R ranged from 1 to 5,
and the mean score was used in the data analysis. The
timeline dimension measures the perceived course or
duration of the illness; a higher score indicates a more
chronic disease. The cyclical timeline subscale measures
the extent of illness variability and unpredictability;
a higher score indicates greater variability. The conse-
quences dimension measures the perceived impact that the
illness has on a patient’s life; a higher score indicates more
serious impacts on a patient’s life. The treatment control
dimension measures the patient’s belief that treatment is
effective in controlling the illness; a higher score indicates
that patients are more confident of treatment. The
personal control subscale measures the patient’s perceived
efficacy in controlling their illness; a higher score means
patients sense more control. The extent to which
a patient’s illness representations can provide a coherent
understanding of the illness was used to measure the illness
coherence. A higher score on this subscale is indicative of
an increased awareness of the illness and the degree to
which it makes sense to the patient. The emotional
representation subscale measures patients’ perceived
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anger, fear, anxiety and depression. A higher score on this
scale is indicative of a greater emotional impact of the
condition.
A list of 19 symptoms associated with high blood pres-
sure was included in the identity subscale. The participants
were instructed to tick either ‘Yes’ or ‘No’ as applicable to
indicate their experience with each symptom, and only
those symptoms that were identified by the patients as
hypertension were counted in the identity score. The
causal attribution parts were not included in the present
study.
Measurement of drug adherence
The Hypertensive Patient’s Drug Adherence Questionnaire
has 10 items, measured on a five-point Likert scale, to assess
a patient’s adherence to the prescribed mediation. This
questionnaire includes the decreasing type of dosage devi-
ation, deviation in timing, and forgetting and stopping to
take medication. The scores of negative statements were
reversed, and, thus, higher scores indicate better adherence
[7]. If the scale score was <4.8, participants were catego-
rized as nonadherent. The reference score was computed
using the following formulas: Y1 Z (0.0018856  systolic
blood pressure) þ 4.99 and Y2 Z (0.0001529  diastolic
blood pressure) þ 4.84. These coefficients were adapted
from the regression analysis results using 140/90 mmHg for
systolic blood pressure and diastolic blood pressure, and the
highest score was used as the cut-off point.
Patient characteristics
These data include sex, age, education level, and whether
patients had diabetes or hyperlipidemia. The co-morbidity
data with diabetes or hyperlipidemia came from the
patients’ medical records. Patients were identified as
having diabetes if they had ICD-9-CM codes 250.xx, or
hyperlipidemia if they had ICD-9-CM codes 272.xx.
Statistical analyses
A cluster analysis was performed to identify clusters of
patients who share a similar pattern of illness perceptions.
Most IPQ-R (Hypertension) subscales were included in this
analysis, except for the coherence and emotional repre-
sentation subscales [17]. The F-test was used to compare
the dimensions of illness perception among clusters.Table 1 Means of illness perceptions for the three clusters.
Subscale Cluster 1
(n Z 54)
Cluster
(n Z 14
Symptom 0.76  1.08 2.36  0.
Emotional representation 2.06  0.64 3.44  0.
Timeline, acute 3.11  0.76 3.25  0.
Timeline, cyclical 2.36  0.75 3.36  0.
Consequences 1.85  0.46 2.97  0.
Personal control 2.93  0.78 3.45  0.
Treatment control 3.83  0.50 4.00  0.
Illness coherence 3.44  1.08 3.14  0.
*** p < 0.001.Associations between patterns of illness perception,
adherence, and patient characteristics were assessed by
the Chi-square test. Results were considered statistically
significant for p < 0.05. All these statistical tests were
performed with SPSS software for Windows (version 13,
SPSS, Chicago).
Results
Sample characteristics
The sample consisted of 117 participants: 78 men (66.7%),
mean age Z 53.8 years old (SD Z 9.49, range Z 27e77
years). Of the participants 40.2% (nZ 47) had an education
level less than junior high school, and 32.5% (n Z 38) and
27.4% (n Z 32) had completed senior high school and
college, respectively. In addition to hypertension, 29.3% of
the participants had hyperlipidemia, and 23.9% had
diabetes.
Illness perception for hypertension
The results indicate that a patient’s perception of hyper-
tension is composed of beliefs about negative conse-
quences, the chronic nature of the disease, the stability of
the disease, the mutual emotional responses, the positive
effect of personal interventions and of medication, and
good coherence. Generally, patients’ perceptions of their
hypertension were that the disease was chronically severe
but stable, and the patients were confident in the treat-
ment and their personal effectiveness. The mean scores are
presented in Table 1.
Hierarchical cluster analysis was performed to identify
different illness perceptions of hypertension using Ward’s
method, and three clusters were generated. The distribu-
tion of clusters was 46.15% participants in cluster 1, 41.88%
in cluster 3, and 11.97% in cluster 2. The patients in cluster
1 displayed more positive beliefs with regard to timeline,
consequences, and less negative emotional responses than
the patients in the other two clusters. However, the
patients in cluster 1 had the weakest personal control. The
patients in cluster 2 had more symptoms than the other
patients, more negative consequences and cyclical time-
line perceptions, and the most negative emotional2
)
Cluster 3
(n Z 49)
All F-test
50 0.31  0.62 0.76  1.06 31.27***
45 2.76  0.89 2.52  0.88 24.11***
64 3.66  0.48 3.35  0.69 9.62***
53 3.30  0.70 2.87  0.85 26.02***
57 2.47  0.70 2.24  0.70 26.68***
52 3.47  0.57 3.22  0.72 9.29***
58 3.38  0.46 3.66  0.55 14.40***
86 3.45  0.98 3.41  1.01 0.55
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strongest belief in treatment control. Cluster 3 had the
highest personal control, the weakest treatment control
belief, and the most chronic disease.
A sex difference was found in only the personal control
dimension, with men having higher personal control than
women (t Z 2.68, p Z 0.008). Older patients were more
negative with regard to the chronic state of the disease,
consequences and emotions. There were no significant
differences concerning the education level and co-
morbidity according to each illness perception identified,
based on t tests and F-tests.
Sample characteristics among clusters
There were more female patients in cluster 1 than in the
other two clusters, and all the patients in cluster 2 were
<60 years old. However, there were no statistically signif-
icant gender or age differences among them. Further, there
were no differences with regard to education and co-
morbidity (Table 2).
Illness perception and adherence
Chi-square tests were performed to identify how illness
perception relates to adherence. The results indicate that
patients differ with regard to drug adherence. Participants
in cluster 1 had a better drug adherence rate (79.6%) than
those in clusters 2 and 3 (42.9 and 65.3%, respectively,
c2 Z 7.67, p < 0.05). Patients with more positive illness
perceptions (except a personal sense of control) had better
drug adherence, and patients with negative illness
perceptions with strong confidence in treatment control
had worse adherence.Table 2 Patient characteristics and adherence among clusters.
Cluster 1
(n Z 54)
Sex
Male 32 (59.3%)
Female 22 (40.7%)
Age (y)
50 15 (27.8%)
51e60 30 (55.6%)
>61 9 (16.7%)
Education
Less than junior high school 22 (40.7%)
Senior high school 18 (33.3%)
College and above 14 (25.9%)
Co-morbidity
Hyperlipidemia 15 (28.3%)
Diabetes 12 (22.2%)
Drug adherence 43 (79.6%)
* p < 0.05.Discussion
We found that participants can be divided into three
categories based on their illness perceptions. The first
cluster had a few physical symptoms and less negative
emotional responses to hypertension, and believed that
hypertension is a more acute disease that is not cyclical or
serious. However, these patients also had the lowest level
of personal sense of control. The second cluster was almost
the opposite of the first cluster. Participants in this cluster
experienced the most symptoms and negative emotional
responses, and they also thought of hypertension as
a chronic, cyclical disease. However, they were positive to
both personal and treatment control beliefs. The third
cluster had fewer symptoms, mutual emotions, the highest
personal control, and the lowest treatment control belief.
The adherence rates were the highest in cluster 1, followed
by clusters 3 and 2, which had the lowest adherence.
Therefore, it may be necessary to pay more attention to
patients with more physical symptoms and negative
emotional responses and to make them confident in the
treatment in a clinical setting.
When patients believed that the treatment could
improve their symptoms, they were more likely to
constantly adhere to the doctor’s prescription. Even though
the medication can lower blood pressure, if the patients
think that the medication is not improving their symptoms,
then their adherence behavior will be poor [11]. Cluster 2
had high personal and treatment control beliefs, which may
indicate that they believe treatment can improve their
symptoms. However, previous research also found that
patients with higher perceived control may have worse
adherence [18], and symptomatic patients are more likely
to change their prescription dose [14]. Cluster 2 had the
highest number of symptoms, and their negative emotionalCluster 2
(n Z 14)
Cluster 3
(n Z 49)
Chi-square
11 (78.6%) 35 (71.4%) 2.73
3 (21.4%) 14 (28.6%)
5 (35.7%) 17 (34.7%) 5.91
9 (64.3%) 20 (40.8%)
0 12 (24.5%)
5 (35.7%) 20 (40.8%) 0.26
5 (35.7%) 15 (30.6%)
4 (28.6%) 14 (28.6%)
5 (35.7%) 14 (28.6%) 0.32
3 (21.4%) 13 (26.5%) 0.32
6 (42.9%) 32 (65.3%) 7.67*
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better adherence, clinical physicians need to note patients’
symptoms and their negative emotional response related to
hypertension.
Cluster 1 had the lowest personal sense of control and
highest adherence, which seems inconsistent with regard to
self-efficacy. However, in some studies, patients who
considered themselves to be unable to control their blood
pressure had higher medication adherence [10]. The
assessment of the severity of the disease and the conse-
quences may also affect adherence. For example, when
patients perceive that they are at a high risk for stroke,
they will worry about blood pressure status, and their
adherence will be better [14].
In the past, one way of promoting healthy behaviors was
by changing the patient’s coping cognition. However, it
would be more effective to change their illness perceptions
or beliefs. Recent research on patients with diabetes shows
that illness representation can predict both coping cogni-
tion and coping behaviors, but the coping cognition is not
the median factor for illness and coping behavior [19]. For
example, it is helpful to correct health beliefs among
myocardial infarction (MI) patients to improve their health
behavior [20]. If acute MI patients believe that their
conditions are controllable, symptomatic and severe, and if
they understand their condition, then they may be more
willing to participate in the following rehabilitation [19]. It
might be beneficial to modify patients’ perceptions of the
chronic state or cyclical nature of hypertension, and
improved patients’ self-efficacy may lead to higher
adherence.
To achieve optimal blood pressure control, patients and
physicians should collaborate. In addition to patient
adherence to treatment, recent research has also focused
on physician factors. Physicians might overestimate
a patient’s control status or the effectiveness of the
treatment [21,22], possibly because poor control may result
if physicians do not change their prescriptions even if the
control targets are not reached [23]. Previous research
demonstrates that when physicians increase the dosage or
change the type of drug, then more patients reach the
desired goal of blood pressure [24]. Hyman and colleagues’
study indicates that, in a national representative sample,
41% of physicians in primary care are not familiar with the
JNC (The Report of the Joint National Committee on
Prevention, Detection, Evaluation, and Treatment of High
Blood Pressure) guidelines [25]. Analyses of the declaration
data of the National Health Insurance demonstrate that
hypertensive patients seldom have regular check-ups, and
physicians’ prescriptions may need to be updated, requiring
future examinations [26]. In addition to improving the
patients’ knowledge of hypertension, changing their
beliefs, and managing their negative emotional responses,
the education of physicians is also an important factor in
hypertension control.Limitations
Because of the small sample size of cluster 2, the gener-
alization of our result might be limited. However, all
participants were uncomplicated, and the result may onlyreflect the illness perceptions and drug adherence in
a relatively healthier hypertensive population. Compared
with previous community studies, patients had higher drug
adherence in this study, possibly as a result of the sampling
by physician referral. It is possible that there was a selec-
tive bias, because those patients who had agreed to
participate might have better doctorepatient relationships
or adherence or because those who had chosen not to
participate might not have this level of drug adherence.Acknowledgments
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